Literature DB >> 22902053

Scleral contact lens management of bilateral exposure and neurotrophic keratopathy.

Fiona Grey1, Fiona Carley, Susmito Biswas, Cindy Tromans.   

Abstract

We report an interesting case of therapeutic scleral lens management of bilateral exposure and neurotrophic keratopathy resulting from bilateral cranial nerve (CN) palsies including V, VI and VII, which caused lagophthalmos and anaesthetic corneas. Subsequent development of severe exposure keratitis with vascularisation and keratinisation of the inferior cornea was previously treated with intensive ocular lubrication, botulinum toxin injections to the upper eyelid levator muscle, temporary tarsorrhophies, bilateral amniotic membrane grafts, punctal plugs, lid taping, gold eyelid weights and soft bandage contact lenses. Corneal integrity was re-established but visual acuity remained significantly compromised by corneal vascularisation, scarring and keratin deposits. Visions on presentation to the contact lens department were R 1.90 logMAR, L 1.86 logMAR. Therapeutic, high Dk, non-fenestrated, saline filled, scleral lenses were fitted. Daily wear of these lenses have protected and hydrated the cornea, enabling corneal surface recovery whilst retaining visual and social function. The visual acuities 6 months post-scleral fitting with lenses in situ are R 0.90 logMAR and L logMAR 0.70.
Copyright © 2012 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22902053     DOI: 10.1016/j.clae.2012.07.009

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  9 in total

1.  [Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].

Authors:  A Schilimow; B Wiechens
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

2.  Corneal nerve structure and function after long-term wear of fluid-filled scleral lens.

Authors:  Yvonne Wang; Daniel L Kornberg; Ryan M St Clair; Michelle Lee; Irma Muhic; Jessica B Ciralsky; Ana Alzaga Fernandez; Priyanka Sood; Kimberly C Sippel; Mark I Rosenblatt
Journal:  Cornea       Date:  2015-04       Impact factor: 2.651

Review 3.  Diagnosis and management of neurotrophic keratitis.

Authors:  Marta Sacchetti; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2014-03-19

4.  The Relationship of Amount of Resection and Time for Recovery of Bell's Phenomenon after Levator Resection in Congenital Ptosis.

Authors:  Ruchi Goel; Divya Kishore; Smriti Nagpal; Sparshi Jain; Tushar Agarwal
Journal:  Open Ophthalmol J       Date:  2017-02-28

Review 5.  Therapeutic uses of scleral contact lenses for ocular surface disease: patient selection and special considerations.

Authors:  Jennifer S Harthan; Ellen Shorter
Journal:  Clin Optom (Auckl)       Date:  2018-07-11

Review 6.  Neurotrophic keratitis: current challenges and future prospects.

Authors:  Piera Versura; Giuseppe Giannaccare; Marco Pellegrini; Stefano Sebastiani; Emilio C Campos
Journal:  Eye Brain       Date:  2018-06-28

Review 7.  New Pharmacological Approaches for the Treatment of Neurotrophic Keratitis.

Authors:  Su Yin Koay; Daniel F P Larkin
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

Review 8.  How Can We Best Measure the Performance of Scleral Lenses? Current Insights.

Authors:  Rute J Macedo-de-Araújo; Daddi Fadel; Melissa Barnett
Journal:  Clin Optom (Auckl)       Date:  2022-04-07

Review 9.  Neurotization of the human cornea - A comprehensive review and an interim report.

Authors:  Anubha Rathi; Nandini Bothra; Smruti R Priyadarshini; Divya S R Achanta; Merle Fernandes; Somasheila I Murthy; Anasua G Kapoor; Tarjani V Dave; Suryasnata Rath; Rajesh Yellinedi; Rambabu Nuvvula; Gautam Dendukuri; Milind N Naik; Muralidhar Ramappa
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.